[A pharmacotherapeutic approach to Parkinsonism].
The Parkinsonism disease has chronical degenerative disease of the nervous system, which has the progressive course. The therapeutic value of the drugs weakens by course of the year, and the nondesired effects become more expressed. Thanks to the researches and new medicaments in the last tenth years have significantly widened the possibility for treating and control of the symptoms of Parkinsonism disease. The knowing of the mechanism of the action dosage, undesired effects, and the interaction of the drugs makes easier the specific parkinsonism therapy.
Zavrsnik
D
D
Farmaceutski fakultet Univerziteta u Sarajevu.
Zulić
I
I
Becić
F
F
D018680:Cholinergic Antagonists / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D018680:Cholinergic Antagonists; D015259:Dopamine Agents